Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | KIF11 | P52732 | 9/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL636461 | 0.84 | SLC6A4 (0.46) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL2837925 | 0.84 | SLC6A4 (0.46) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL162234 | 0.84 | SLC6A4 (0.46) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL30664386 | 0.82 | SLC6A4 (0.44) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL5479687 | 0.81 | KIF11 (0.43) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL14596128 | 0.78 | SLC6A4 (0.47) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL635988 | 0.78 | SLC6A4 (0.47) | SLC6A4MAOAMAOBKIF11CYP1A2 | |
| SCHEMBL10038034 | 0.78 | ACHE (0.52) | SLC6A4MAOAMAOBKIF11CA1 | |
| SCHEMBL16329073 | 0.78 | ACHE (0.52) | SLC6A4MAOAMAOBKIF11CA1 | |
| SCHEMBL19594180 | 0.75 | TAS1R3 (0.43) | SLC6A4MAOAMAOBKIF11CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7462722-B2 | Process for producing optically active-3-quinuclidinols | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-12-09 | — | — | US | disclosed |
| EP-1650207-B1 | Process for producing optically active 3-quinuclidinols | TAKASAGO PERFUMERY CO LTD (JP) | 2007-06-27 | — | — | EP | disclosed |
| EP-1650207-A1 | Process for producing optically active 3-quinuclidinols | Takasago International Corporation (JP) | 2006-04-26 | — | — | EP | disclosed |
| US-20060047122-A1 | Process for producing optically active-3-quinuclidinols | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047122-A1 | Process for producing optically active-3-quinuclidinols | DHPS, QDPR, TYR | SLC6A4 3322/4885MAOA 702/4885MAOB 954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.